Cited by 561CRISPR and Genetic EngineeringVirus-based gene therapy researchHematopoietic Stem Cell Transplantation

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Targeted genome editing in human repopulating haematopoietic stem cells

Open access

Genovese, Pietro, Schiroli, Giulia, Escobar, Giulia, Di Tomaso, Tiziano, Firrito, Claudia, Calabria, Andrea, Moi, Davide, Mazzieri, Roberta, Bonini, Chiara, Holmes, Michael C., Gregory, Philip D., van der Burg, Mirjam, Gentner, Bernhard, Montini, Eugenio, Lombardo, Angelo, Naldini, Luigi·2014·Nature

DOI 10.1038/nature13420PMC PMC4082311

Open this paper in CoChat — free account

Abstract

Targeted genome editing by artificial nucleases has brought the goal of site-specific transgene integration and gene correction within the reach of gene therapy. However, its application to long-term repopulating haematopoietic stem cells (HSCs) has remained elusive. Here we show that poor permissiveness to gene transfer and limited proficiency of the homology-directed DNA repair pathway constrain gene targeting in human HSCs. By tailoring delivery platforms and culture conditions we overcame these barriers and provide stringent evidence of targeted integration in human HSCs by long-term multilineage repopulation of transplanted mice. We demonstrate the therapeutic potential of our strategy by targeting a corrective complementary DNA into the IL2RG gene of HSCs from healthy donors and a subject with X-linked severe combined immunodeficiency (SCID-X1). Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations. These results open up new avenues for treating SCID-X1 and other diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature13420

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Clustal W and Clustal X version 2.0
Larkin, M., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., López, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,598
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Self-citation
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · cited 1×
“Artificial endonucleases, such as Zinc Finger Nucleases (ZFNs) 11 , Transcription Activator-Like Effector Nucleases (TALENs) 12 , and RNA-guided nucleases (CRISPR/Cas) 13 brought the possibility of gene targeting within the reach of gene therapy 14,15 .”
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,642
Self-citation
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 1×
“Hematopoietic Stem Cells (HSC)-based gene therapy has provided therapeutic benefit in primary immunodeficiencies 1,2 , thalassemia 3 and leukodystrophies 4,5 .”

Flagged first, then by citations

Show all 44 references

Sorted by citations

Items 201–300 of 561

Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation
Zhou, X., Naik, S., Dakhova, O., Dotti, G., Heslop, H. E., & Brenner, M. K. (2015) · Molecular Therapy · doi:10.1038/mt.2015.234 · Cited by 41
High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
Sürün, D., Schwäble, J., Tomasovic, A., Ehling, R., Stein, S., Kurrle, N., von Melchner, H., & Schnütgen, F. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2017.11.001 · Cited by 39
Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
Zhang, Y., Long, C., Bassel‐Duby, R., & Olson, E. N. (2018) · Physiological Reviews · doi:10.1152/physrev.00046.2017 · Cited by 42
Highly efficient genome editing of human hematopoietic stem cells via a nano-silicon-blade delivery approach
Ma, Y., Han, X., Bustamante, O. Q., de Castro, R. B., Zhang, K., Zhang, P., Li, Y., Liu, Z., Liu, X., Mauro Ferrari, B., et al. (2017) · Integrative Biology · doi:10.1039/c7ib00060j · Cited by 37
Therapeutic gene editing in haematological disorders with CRISPR /Cas9
Jensen, T. I., Axelgaard, E., & Bak, R. O. (2019) · British Journal of Haematology · doi:10.1111/bjh.15851 · Cited by 40
Targeted Gene Delivery: Where to Land
Pavani, G., & Amendola, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.609650 · Cited by 41
Ex vivo expansion of hematopoietic stem cells: Finally transitioning from the lab to the clinic
Zimran, E., Papa, L., & Hoffman, R. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100853 · Cited by 39
Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence
Clément, F., Grockowiak, É., Zylbersztejn, F., Fossard, G., Gobert, S., & Maguer‐Satta, V. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.07.03 · Cited by 39
Genetic therapies for sickle cell disease
Esrick, E. B., & Bauer, D. E. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.04.014 · Cited by 39
Gene therapy and genome editing for primary immunodeficiency diseases
Zhang, Z., Thrasher, A. J., & Zhang, F. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.07.007 · Cited by 38
UM171 Enhances Lentiviral Gene Transfer and Recovery of Primitive Human Hematopoietic Cells
Ngom, M., Imren, S., Maetzig, T., Adair, J. E., Knapp, D. J. H. F., Chagraoui, J., Fares, I., Bordeleau, M.-È., Sauvageau, G., Leboulch, P., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.06.009 · Cited by 37
CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation
Daniel-Moreno, A., Lamsfus‐Calle, A., Raju, J., Antony, J. S., Handgretinger, R., & Mezger, M. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0510-8 · Cited by 40
Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial
Brendel, C., Río, P., & Verhoeyen, E. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113711 · Cited by 39
Cellular Innate Immunity and Restriction of Viral Infection: Implications for Lentiviral Gene Therapy in Human Hematopoietic Cells
Kajaste‐Rudnitski, A., & Naldini, L. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.036 · Cited by 37
Self-citation
From fiction to science: clinical potentials and regulatory considerations of gene editing
Schacker, M., & Seimetz, D. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0244-7 · Cited by 36
Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
Azhagiri, M. K. K., Babu, P., Venkatesan, V., & Thangavel, S. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02565-6 · Cited by 35
CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing
Ferreira, P., & Choupina, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07442-w · Cited by 39
Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
Amiri, M., Moaveni, A. K., Zolbin, M. M., Shademan, B., & Nourazarian, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462697 · Cited by 37
Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells
Zeng, J., Nguyen, M. A., Liu, P., da Silva, L. F., Levesque, S., Lin, L. Y., Justus, D. G., Petri, K., Clement, K., Porter, S. N., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.11.001 · Cited by 36
Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells
Garate, Z., Bustamante, O. Q., Crane, A. M., Olivier, E. N., Poirot, L., Galetto, R., Kosinski, P. A., Hill, C., Kung, C. K.-H., Agirre, X., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.002 · Cited by 34
Use of genome-editing tools to treat sickle cell disease
Tasan, I., Jain, S., & Zhao, H. (2016) · Human Genetics · doi:10.1007/s00439-016-1688-0 · Cited by 36
Gene therapy and gene editing strategies for hemoglobinopathies
Lidonnici, M. R., & Ferrari, G. (2018) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.12.001 · Cited by 34
Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
Bandara, R. A., Chen, Z. R., & Hu, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00662-w · Cited by 35
A genome editing primer for the hematologist
Hoban, M. D., & Bauer, D. E. (2016) · Blood · doi:10.1182/blood-2016-01-678151 · Cited by 32
Use of Zinc-Finger Nucleases for Crop Improvement
Davies, J. P., Kumar, S., & Sastry, L. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.03.006 · Cited by 37
Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation
Capo, V., Castiello, M. C., Fontana, E., Penna, S., Bosticardo, M., Draghici, E., Poliani, P. L., Sergi, L. S., Rigoni, R., Cassani, B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.11.015 · Cited by 32
Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases
Huang, N., Huang, Z., Gao, M., Luo, Z., Zhou, F., Liu, L., Xiao, Q., Wang, X., & Feng, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0732-4 · Cited by 32
Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing
Smith, L. J., Wright, J. B., Clark, G., Ul-Hasan, T., Jin, X., Fong, A., Chandra, M., Martin, T. S., Rubin, H. L., Knowlton, D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802343115 · Cited by 33
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering
Piras, F., & Kajaste‐Rudnitski, A. (2020) · Gene Therapy · doi:10.1038/s41434-020-0175-3 · Cited by 32
Characterization of naked mole‐rat hematopoiesis reveals unique stem and progenitor cell patterns and neotenic traits
Emmrich, S., Trapp, A., Zakusilo, F. T., Straight, M. E., Ying, K., Tyshkovskiy, A., Mariotti, M., Gray, S., Zhang, Z., Drage, M. G., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109694 · Cited by 32
The p53 challenge of hematopoietic stem cell gene editing
Dorset, S. R., & Bak, R. O. (2023) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2023.06.003 · Cited by 33
Peripheral Blood Stem Cell Mobilization: a Look Ahead
Pelus, L. M., & Broxmeyer, H. E. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0141-9 · Cited by 33
In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization
Shakirova, A. I., Karpov, T. E., Komarova, Y., & Lepik, K. V. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1068637 · Cited by 33
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells
Baik, R., Cromer, M. K., Glenn, S. E., Vakulskas, C. A., Chmielewski, K. O., Dudek, A. M., Feist, W. N., Klermund, J., Shipp, S., Cathomen, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-43413-w · Cited by 31
Synthetic Biology—Toward Therapeutic Solutions
Haellman, V., & Fussenegger, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.08.020 · Cited by 34
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA)
Ali, J. H., & Walter, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03041-2 · Cited by 36
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors
Sauer, A. V., Lorenzo, B. D., Carriglio, N., & Aiuti, A. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000114 · Cited by 32
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia
Osborn, M. J., Lonetree, C.-L., Webber, B. R., Patel, D., Dunmire, S. K., DeFeo, A. P., McElroy, A. N., MacMillan, M. L., Wagner, J. E., Blazar, B. R., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0149 · Cited by 34
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
Patsali, P., Kleanthous, M., & Lederer, C. W. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00391-4 · Cited by 31
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
Rai, R., Thrasher, A. J., & Cavazza, A. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.185 · Cited by 30
Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia
Gray, D., Villegas, I. J., Long, J. D., Santos, J., Keir, A., Abele, A. N., Kuo, C. Y., & Kohn, D. B. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0080 · Cited by 34
Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa
Izmiryan, A., Danos, O., & Hovnanian, A. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.028 · Cited by 32
Morbidities in non‐transfusion‐dependent thalassemia
Saliba, A. N., & Taher, A. T. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13083 · Cited by 30
Gene editing and its application for hematological diseases
Osborn, M. J., Belanto, J. J., Tolar, J., & Voytas, D. F. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2017-z · Cited by 32
Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
Chen, C., Guderyon, M. J., Li, Y., Ge, G., Bhattacharjee, A., Ballard, C., He, Z., Masliah, E., Clark, R. A., O’Connor, J. C., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.013 · Cited by 31
The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells
Sharma, R., Dever, D. P., Lee, C. M., Azizi, A., Pan, Y., Camarena, J., Köhnke, T., Bao, G., Porteus, M. H., & Majeti, R. (2021) · Nature Communications · doi:10.1038/s41467-020-20792-y · Cited by 30
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion
Becker, H., Ishida, R., Wilkinson, A. C., Kimura, T., Lee, M. S. J., Coban, C., Ota, Y., Tanaka, Y., Roskamp, M. M., Sano, T., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.06.002 · Cited by 35
Multiparametric Whole Blood Dissection: A one‐shot comprehensive picture of the human hematopoietic system
Ricci, L. B., Scala, S., Milani, R., Migliavacca, M., Rovelli, A., Bernardo, M. E., Ciceri, F., Aiuti, A., & Biasco, L. (2017) · Cytometry Part A · doi:10.1002/cyto.a.23148 · Cited by 29
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells
Long, J. D., Hoban, M. D., Cooper, A. R., Kaufman, M. L., Kuo, C. Y., Campo-Fernández, B., Lumaquin, D., Hollis, R. P., Wang, X., Kohn, D. B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.001 · Cited by 30
Cytokine combinations for human blood stem cell expansion induce cell-type– and cytokine-specific signaling dynamics
Wang, W., Zhang, Y., Dettinger, P., Reimann, A., Kull, T., Loeffler, D., Manz, M. G., Lengerke, C., & Schroeder, T. (2021) · Blood · doi:10.1182/blood.2020008386 · Cited by 29
Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
Tyumentseva, M. A., Tyumentsev, A. I., & Акимкин, В. Г. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259812 · Cited by 30
Molecular feature and therapeutic perspectives of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
Huang, Q., Liu, X., Zhang, Y., Huang, J., Li, D., & Li, B. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.011 · Cited by 30
High-fidelity PAMless base editing of hematopoietic stem cells to treat chronic granulomatous disease
Bzhilyanskaya, V., Ma, L., Liu, S., Fox, L. R., Whittaker, M. N., Meis, R. J., Choi, U., Lawson, A., Ma, M., Theobald, N., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj6779 · Cited by 27
The non-canonical Wnt receptor Ryk regulates hematopoietic stem cell repopulation in part by controlling proliferation and apoptosis
Famili, F., García-Pérez, L., Naber, B. A. E., Noordermeer, J. N., Fradkin, L. G., & Staal, F. J. T. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.380 · Cited by 29
Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
Paschoudi, K., Yannaki, E., & Psatha, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119527 · Cited by 30
Intracellular delivery of biologic therapeutics by bacterial secretion systems
Walker, B. J., Stan, G.-B. V., & Polizzi, K. M. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.7 · Cited by 28
Epitope prime editing shields hematopoietic cells from CD123 immunotherapy for acute myeloid leukemia
Ji, R.-J., Cao, G.-H., Zhao, W., Wang, M.-Y., Gao, P., Zhang, Y.-Z., Wang, X.-B., Qiu, H.-Y., Chen, D.-D., Tong, X.-H., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.003 · Cited by 30
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 31
Genome engineering: the next genomic revolution
Gersbach, C. A. (2014) · Nature Methods · doi:10.1038/nmeth.3113 · Cited by 27
Advances in the gene therapy of monogenic blood cell diseases
Bueren, J. A., Bustamante, O. Q., Almarza, E., Navarro, S., Rı́o, P., Segovia, J. C., & Güenechea, G. (2019) · Clinical Genetics · doi:10.1111/cge.13593 · Cited by 28
Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches
Lamsfus‐Calle, A., Daniel-Moreno, A., Ureña-Bailén, G., Raju, J., Antony, J. S., Handgretinger, R., & Mezger, M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100641 · Cited by 29
The potential for tumor suppressor gene therapy in head and neck cancer.
Birkeland, A. C., Ludwig, M., Spector, M. E., & Brenner, J. C. (2016) · PubMed · Cited by 27
Lipid nanoparticle-mediated silencing of osteogenic suppressor GNAS leads to osteogenic differentiation of mesenchymal stem cells in vivo
Basha, G., Cottle, A. G., Pretheeban, T., Chan, K. Y. T., Witzigmann, D., Young, R. N., Rossi, F. M. V., & Cullis, P. R. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.012 · Cited by 26
Screening for genes that regulate the differentiation of human megakaryocytic lineage cells
Zhu, F., Feng, M., Sinha, R., Seita, J., Mori, Y., & Weissman, I. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805434115 · Cited by 26
Promise of gene therapy to treat sickle cell disease
Romero, Z. G., DeWitt, M. A., & Walters, M. C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1536119 · Cited by 27
Gene editing of PKLR gene in human hematopoietic progenitors through 5’ and 3’ UTR modified TALEN mRNA
Bustamante, O. Q., Fañanas-Baquero, S., Orman, I., Torres-Ruiz, R., Duchateau, P. N., Poirot, L., Gouble, A., Bueren, J. A., & Segovia, J. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223775 · Cited by 26
The complexity of epigenetic diseases
Brazel, A. J., & Vernimmen, D. (2015) · The Journal of Pathology · doi:10.1002/path.4647 · Cited by 25
Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection
Cottle, R. N., Lee, C. M., Archer, D. R., & Bao, G. (2015) · Scientific Reports · doi:10.1038/srep16031 · Cited by 26
Genetic Engineering and Manufacturing of Hematopoietic Stem Cells
Wang, X., & Rivière, I. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.03.003 · Cited by 25
Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP
Houghton, B. C., Panchal, N., Haas, S. A., Chmielewski, K. O., Hildenbeutel, M., Whittaker, T. E., Mussolino, C., Cathomen, T., Thrasher, A. J., & Booth, C. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.828489 · Cited by 26
A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
della Volpe, L., Midena, F., Vacca, R., Tavella, T., Alessandrini, L., Farina, G., Brandas, C., Furno, E. L., Giannetti, K., Carsana, E., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101823 · Cited by 28
Self-citation
Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts
Néri, T., Muggeo, S., Paulis, M., Caldana, M. E., Crisafulli, L., Strina, D., Focarelli, M. L., Faggioli, F., Recordati, C., Scaramuzza, S., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.08.005 · Cited by 25
Self-citation
Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells
Heinz, N., Ehrnström, B., Schambach, A., Schwarzer, A., Modlich, U., & Schiedlmeier, B. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0284 · Cited by 24
Gene Therapy and Genome Editing
Boulad, F., Mansilla‐Soto, J., Cabriolu, A., Rivière, I., & Sadelain, M. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.007 · Cited by 24
Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break
Rogers, G. L., Chen, H.-Y., Morales, H., & Cannon, P. M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.08.019 · Cited by 24
Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System
Mussolino, C., Alzubi, J., Pennucci, V., Turchiano, G., & Cathomen, T. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.149 · Cited by 23
CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside
Humbert, O., Samuelson, C., & Kiem, H. (2020) · British Journal of Haematology · doi:10.1111/bjh.16807 · Cited by 27
Electrotransfer for nucleic acid and protein delivery
Muralidharan, A., & Boukany, P. E. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.11.009 · Cited by 25
Targeted, homology-driven gene insertion in stem cells by ZFN-loaded ‘all-in-one’ lentiviral vectors
Cai, Y., Laustsen, A., Zhou, Y., Sun, C., Anderson, M. V., Li, S., Uldbjerg, N., Luo, Y., Jakobsen, M. R., & Mikkelsen, J. G. (2016) · eLife · doi:10.7554/elife.12213 · Cited by 25
CRISPR/Cas9: A tool for immunological research
Hochheiser, K., Kueh, A. J., Gebhardt, T., & Herold, M. J. (2018) · European Journal of Immunology · doi:10.1002/eji.201747131 · Cited by 23
Reprogramming of Melanoma Tumor‐Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
Saito, H., Okita, K., Fusaki, N., Sabel, M. S., Chang, A. E., & Ito, F. (2015) · Stem Cells International · doi:10.1155/2016/8394960 · Cited by 22
Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potency
Zakas, P. M., Cunningham, S. C., Doherty, A., van Dijk, E. B., Ibraheim, R., Yu, S., Mekonnen, B. D., Lang, B., English, E. J., Sun, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.06.021 · Cited by 22
Self-citation
Genome Editing: A Tool For Research and Therapy: Targeted genome editing hits the clinic
Lombardo, A., & Naldini, L. (2014) · Nature Medicine · doi:10.1038/nm.3721 · Cited by 24
Self-citation
CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts
de Carvalho, T. G., Schuh, R. S., Pasqualim, G., Pellenz, F. M., Filippi‐Chiela, E. C., Giugliani, R., Baldo, G., & Matte, Ú. D. S. (2018) · Gene · doi:10.1016/j.gene.2018.08.004 · Cited by 22
NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells
Brault, J., Vigne, B., Meunier, M., Beaumel, S., Mollin, M., Park, S., & Stasia, M. J. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.005 · Cited by 23
Clinically relevant gene editing in hematopoietic stem cells for the treatment of pyruvate kinase deficiency
Fañanas-Baquero, S., Bustamante, O. Q., Dever, D. P., Alberquilla, O., Sánchez‐Domínguez, R., Camarena, J., Ojeda-Pérez, I., Dessy-Rodríguez, M., Turk, R., Schubert, M. S., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.001 · Cited by 22
Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases
Cruz, L. J., Rezaei, S., Grosveld, F. G., Philipsen, S., & Eich, C. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1030285 · Cited by 23
CRISPR‐Cas9: A cornerstone for the evolution of precision medicine
Razzouk, S. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12271 · Cited by 22
Tissue Engineering and Regenerative Medicine in Basic Research: A Year in Review of 2014
Huang, J., Lin, X., Shi, Y., & Liu, W. (2015) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2014.0626 · Cited by 23
Proven and novel strategies for efficient editing of the human genome
Mussolino, C., Mlambo, T., & Cathomen, T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.08.008 · Cited by 21
Expanding the genetic code of the human hematopoietic system
Shao, S., Koh, M., & Schultz, P. G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914408117 · Cited by 21
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
Christen, F., Hablesreiter, R., Hoyer, K., Hennch, C., Maluck-Böttcher, A., Segler, A., Madadi, A., Frick, M., Bullinger, L., Briest, F., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01469-x · Cited by 22
Genome Editing: Potential Treatment for Lysosomal Storage Diseases
de Carvalho, T. G., Matte, Ú. D. S., Giugliani, R., & Baldo, G. (2015) · Current Stem Cell Reports · doi:10.1007/s40778-014-0007-8 · Cited by 23
Optimizing autologous cell grafts to improve stem cell gene therapy
Psatha, N., Karponi, G., & Yannaki, E. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.04.007 · Cited by 21
A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells
Jayavaradhan, R., Pillis, D. M., & Malik, P. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.005 · Cited by 20
Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis
de Sio, F. R. S., Passerini, L., Restelli, S., Valente, M. M., Pramov, A., Maccari, M. E., Sanvito, F., Roncarolo, M. G., Porteus, M. H., & Bacchetta, R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.015 · Cited by 21
Treatment of β 654 ‐thalassaemia by TALEN s in a mouse model
Fang, Y., Cheng, Y., Lü, D., Gong, X., Yang, G., Gong, Z., Zhu, Y., Sang, X. M., Fan, S., Zhang, J., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12491 · Cited by 22
CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies
Ureña-Bailén, G., Lamsfus‐Calle, A., Daniel-Moreno, A., Raju, J., Schlegel, P., Seitz, C. M., Atar, D., Antony, J. S., Handgretinger, R., & Mezger, M. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz039 · Cited by 23
Gene/Cell Therapy Approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome
Passerini, L., de Sio, F. R. S., Porteus, M. H., & Bacchetta, R. (2014) · Current Gene Therapy · doi:10.2174/1566523214666141001123828 · Cited by 21
Mouse models in hematopoietic stem cell gene therapy and genome editing
Radtke, S., Humbert, O., & Kiem, H. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113692 · Cited by 22

Authors: Genovese, P., Schiroli, G., Escobar, G., Di Tomaso, T., Firrito, C., Calabria, A., Moi, D., Mazzieri, R., Bonini, C., Holmes, M. C., Gregory, P. D., van der Burg, M., Gentner, B., Montini, E., Lombardo, A., & Naldini, L.
Affiliations: The San Raffaele Telethon Institute for Gene Therapy (IT)
Vita-Salute San Raffaele University (IT)
IRCCS Ospedale San Raffaele (IT)
Sangamo BioSciences (United States) (US)
Erasmus MC (NL)
Corresponding author: Naldini, Luigi
ORCID: Genovese, Pietro
Schiroli, Giulia
Escobar, Giulia
Firrito, Claudia
Calabria, Andrea
Moi, Davide
Mazzieri, Roberta
Bonini, Chiara
Holmes, Michael C.
Gregory, Philip D.
van der Burg, Mirjam
Gentner, Bernhard
Montini, Eugenio
Lombardo, Angelo
Naldini, Luigi
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2014-05-28
Volume: 510
Issue: 7504
Pages: 235-240
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature13420
PMC: PMC4082311
OpenAlex: W1995497292
Cited by: 555
References: 44
Citations by year: 2026: 7 · 2025: 20 · 2024: 23 · 2023: 32 · 2022: 42 · 2021: 51 · 2020: 43 · 2019: 50 · 2018: 57 · 2017: 57 · 2016: 71 · 2015: 77 · 2014: 24
FWCI: 28.82
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
PubMed Central (acceptedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
RePEc: Research Papers in Economics (submittedVersion)
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords: targeted genome editing, hematopoietic stem cells, homology-directed repair, gene targeting, IL2RG, X-linked severe combined immunodeficiency, gene therapy, transgene integration
MeSH terms: Animals, Endonucleases, Fetal Blood, Hematopoiesis, Hematopoietic Stem Cells, Humans, Male, Mutation, Genome, Human, DNA, Complementary, Hematopoietic Stem Cell Transplantation, Gene Targeting, Antigens, CD34, Mice, Targeted Gene Repair, Interleukin Receptor Common gamma Subunit, X-Linked Combined Immunodeficiency Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Targeted genome editing in human repopulating haematopoietic stem cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks